Polar Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Polar Capital’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$60.7M	Buy	932,944 +235,906	+34%	+$15.5M	0.45%	66
2020 Q2	$51M	Sell	697,038 -178,672	-20%	-$9.51M	0.44%	71
2020 Q1	$29.8M	Buy	875,710 +274,340	+46%	+$12.5M	0.32%	98
2019 Q4	$32.7M	Buy	601,370 +501,370	+501%	+$24.8M	0.28%	118
2019 Q3	$4.17M	Sell	100,000 -50,000	-33%	-$2.11M	0.04%	238
2019 Q2	$6.57M	Buy	150,000 +12,669	+9%	+$714K	0.06%	216
2019 Q1	$7.07M	Sell	137,331 -12,669	-8%	-$547K	0.07%	203
2018 Q4	$5.55M	Buy	+150,000	New	+$5.41M	0.06%	206
2018 Q3	–	Sell	-199,600	Closed	-$7.89K	–	294
2018 Q2	$7.89K	Buy	+199,600	New	+$6.33M	0.05%	201

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital's BHVN Position: Q3 2020 in Review

Polar Capital increased its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 34% in Q3 2020, buying an estimated $15.5M and bringing the position to 932,944 shares worth $60.7M. The position accounts for 0.45% of the portfolio, ranked #66.

Polar Capital first reported a position in BHVN in Q2 2018 and has held it in 9 quarters since. 215 funds tracked by Wall St. Rank hold BHVN as of Q3 2020.

Polar Capital held 932,944 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $60.7M as of Q3 2020.
Polar Capital bought 235,906 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2020, an estimated $15.5M.
Biohaven Pharmaceutical Holding Company Ltd. made up 0.45% of Polar Capital's portfolio in Q3 2020, its #66 holding.
Polar Capital first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and has held it in 9 quarters since.
215 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.